NASDAQ:CPIX - Cumberland Pharmaceuticals Stock Price, Price Target & More

$6.70 +0.19 (+2.92 %)
(As of 04/23/2018 03:18 PM ET)
Previous Close$6.51
Today's Range$6.45 - $6.89
52-Week Range$5.39 - $7.96
Volume1,108 shs
Average Volume16,652 shs
Market Capitalization$101.90 million
P/E Ratio-93.00
Dividend YieldN/A
Beta0.69

About Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals logoCumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing branded prescription products for hospital acute care and gastroenterology markets in the United States and internationally. It marketed products include Acetadote (acetylcysteine) injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) injection for the treatment of pain and fever; Kristalose (lactulose) for oral solution, a prescription laxative; Vaprisol (conivaptan) injection for treating hyponatremia; Omeclamox-Pak for the treatment of H. pylori infection and duodenal ulcer disease; and Ethyol (amifostine) for injection to treat oncology patients. The company's product candidates in Phase II clinical trials comprise Hepatoren (ifetroban) injection for the treatment of hepatorenal syndrome; Boxaban (ifetroban) oral capsule for the treatment of aspirin-exacerbated respiratory disease; Vasculan (ifetroban) oral capsule for the treatment of systemic sclerosis; and Portaban for the treatment of portal hypertension. Its pre-approval products consist of Methotrexate injection for treating active rheumatoid, juvenile idiopathic, and psoriatic arthritis, as well as disabling psoriasis; and Totect injection for emergency oncology intervention, which helps to reverse the toxic effects of anthracycline chemotherapy in case of extravasation. The company markets and sells its products through sales representatives and district managers. Cumberland Pharmaceuticals Inc. has a strategic alliance with Clinigen Group plc, Nordic Group B.V., and Cumberland Emerging Technologies. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Receive CPIX News and Ratings via Email

Sign-up to receive the latest news and ratings for CPIX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
SymbolNASDAQ:CPIX
CUSIP23077010
Phone615-255-0068

Debt

Debt-to-Equity Ratio0.15%
Current Ratio3.88%
Quick Ratio3.50%

Price-To-Earnings

Trailing P/E Ratio-93.00
Forward P/E Ratio-29.13
P/E GrowthN/A

Sales & Book Value

Annual Sales$41.15 million
Price / Sales2.55
Cash Flow$0.1078 per share
Price / Cash62.13
Book Value$4.06 per share
Price / Book1.65

Profitability

EPS (Most Recent Fiscal Year)($0.07)
Net Income$-7,970,000.00
Net Margins-19.39%
Return on Equity-1.55%
Return on Assets-1.14%

Miscellaneous

Employees84
Outstanding Shares15,650,000

How to Become a New Pot Stock Millionaire

Cumberland Pharmaceuticals (NASDAQ:CPIX) Frequently Asked Questions

What is Cumberland Pharmaceuticals' stock symbol?

Cumberland Pharmaceuticals trades on the NASDAQ under the ticker symbol "CPIX."

How were Cumberland Pharmaceuticals' earnings last quarter?

Cumberland Pharmaceuticals (NASDAQ:CPIX) posted its earnings results on Tuesday, March, 6th. The specialty pharmaceutical company reported $0.01 earnings per share for the quarter. The specialty pharmaceutical company had revenue of $11.65 million for the quarter. Cumberland Pharmaceuticals had a negative net margin of 19.39% and a negative return on equity of 1.55%. View Cumberland Pharmaceuticals' Earnings History.

When is Cumberland Pharmaceuticals' next earnings date?

Cumberland Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Monday, May, 21st 2018. View Earnings Estimates for Cumberland Pharmaceuticals.

What price target have analysts set for CPIX?

1 analysts have issued 12-month price targets for Cumberland Pharmaceuticals' stock. Their forecasts range from $9.25 to $9.25. On average, they expect Cumberland Pharmaceuticals' stock price to reach $9.25 in the next twelve months. View Analyst Ratings for Cumberland Pharmaceuticals.

Who are some of Cumberland Pharmaceuticals' key competitors?

Who are Cumberland Pharmaceuticals' key executives?

Cumberland Pharmaceuticals' management team includes the folowing people:
  • Mr. A. J. Kazimi MBA, Founder, Chairman, Chief Exec. Officer and Pres (Age 60)
  • Mr. Michael P. Bonner, Chief Financial Officer and Sr. Director of Fin. & Accounting (Age 41)
  • Mr. Leo B. Pavliv R.Ph., Chief Devel. Officer and Exec. VP of Operations (Age 57)
  • Mr. James Lowrance Herman, Chief Compliance Officer and Sr. VP of National Accounts (Age 63)
  • Mr. Martin E. Cearnal, Chief Commercial Officer, Exec. VP and Director (Age 73)

Has Cumberland Pharmaceuticals been receiving favorable news coverage?

News articles about CPIX stock have trended somewhat positive recently, according to Accern Sentiment. The research group rates the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Cumberland Pharmaceuticals earned a media sentiment score of 0.16 on Accern's scale. They also gave media stories about the specialty pharmaceutical company an impact score of 44.54 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

How do I buy shares of Cumberland Pharmaceuticals?

Shares of CPIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cumberland Pharmaceuticals' stock price today?

One share of CPIX stock can currently be purchased for approximately $6.70.

How big of a company is Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals has a market capitalization of $101.90 million and generates $41.15 million in revenue each year. The specialty pharmaceutical company earns $-7,970,000.00 in net income (profit) each year or ($0.07) on an earnings per share basis. Cumberland Pharmaceuticals employs 84 workers across the globe.

How can I contact Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals' mailing address is 2525 WEST END AVENUE SUITE 950, NASHVILLE TN, 37203. The specialty pharmaceutical company can be reached via phone at 615-255-0068 or via email at [email protected]


MarketBeat Community Rating for Cumberland Pharmaceuticals (CPIX)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  70 (Vote Outperform)
Underperform Votes:  73 (Vote Underperform)
Total Votes:  143
MarketBeat's community ratings are surveys of what our community members think about Cumberland Pharmaceuticals and other stocks. Vote "Outperform" if you believe CPIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CPIX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cumberland Pharmaceuticals (NASDAQ:CPIX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Cumberland Pharmaceuticals in the last 12 months. Their average twelve-month price target is $9.25, suggesting that the stock has a possible upside of 38.06%. The high price target for CPIX is $9.25 and the low price target for CPIX is $9.25. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyN/AN/AN/A
Consensus Rating Score: 3.00N/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $9.25N/AN/AN/A
Price Target Upside: 38.06% upsideN/AN/AN/A

Cumberland Pharmaceuticals (NASDAQ:CPIX) Consensus Price Target History

Price Target History for Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals (NASDAQ:CPIX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/17/2018B. RileyInitiated CoverageBuy$9.25HighView Rating Details
(Data available from 4/23/2016 forward)

Earnings

Cumberland Pharmaceuticals (NASDAQ:CPIX) Earnings History and Estimates Chart

Earnings by Quarter for Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals (NASDAQ:CPIX) Earnings Estimates

2018 EPS Consensus Estimate: ($0.22)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.02)($0.02)($0.02)
Q2 20181($0.09)($0.09)($0.09)
Q3 20181($0.06)($0.06)($0.06)
Q4 20181($0.05)($0.05)($0.05)

Cumberland Pharmaceuticals (NASDAQ CPIX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/14/2018N/AView Earnings Details
3/6/2018Q4 2017$0.01$11.65 millionViewN/AView Earnings Details
11/7/2017Q3 2017($0.01)$11.20 millionViewN/AView Earnings Details
8/8/2017Q2 2017($0.07)$8.67 millionViewListenView Earnings Details
5/15/2017Q1 2017($0.08)$9.64 millionViewN/AView Earnings Details
3/7/2017Q4 2016$0.05$9.08 millionViewListenView Earnings Details
11/1/2016Q316$0.01$7.90 million$8.80 millionViewN/AView Earnings Details
8/2/2016Q2 2016$0.03$7.42 millionViewN/AView Earnings Details
5/10/2016Q116$0.02$8.70 million$7.70 millionViewListenView Earnings Details
3/3/2016Q4 2015$0.02$8.04 millionViewN/AView Earnings Details
11/3/2015Q3 2015$0.03$7.89 millionViewN/AView Earnings Details
8/4/2015Q2 2015$0.07$8.91 millionViewN/AView Earnings Details
5/7/2015Q115$0.09$8.10 million$8.70 millionViewN/AView Earnings Details
3/3/2015Q4 2014$0.09$9.33 millionViewN/AView Earnings Details
11/4/2014Q3 2014$0.04$9.73 millionViewN/AView Earnings Details
8/5/2014Q2 2014$0.04$9.75 millionViewN/AView Earnings Details
5/13/2014Q114$0.02$10.26 million$8.09 millionViewN/AView Earnings Details
3/4/2014Q4 13$0.05($0.08)$8.16 millionViewN/AView Earnings Details
11/5/2013Q313($0.04)$7.60 million$6.50 millionViewN/AView Earnings Details
8/6/2013Q2 2013$0.02($0.03)$9.40 million$7.10 millionViewN/AView Earnings Details
5/2/2013Q113$0.05$0.05$10.00 million$10.30 millionViewN/AView Earnings Details
2/28/2013Q4 2012$0.14$0.09$13.87 million$13.70 millionViewN/AView Earnings Details
11/1/2012Q312$0.09$0.10$13.05 million$12.50 millionViewN/AView Earnings Details
8/2/2012$0.07$0.09ViewN/AView Earnings Details
5/3/2012$0.05$0.02ViewN/AView Earnings Details
2/29/2012$0.05$0.04ViewN/AView Earnings Details
11/3/2011$0.06$0.09ViewN/AView Earnings Details
8/4/2011$0.04$0.11ViewN/AView Earnings Details
5/5/2011$0.03$0.03ViewN/AView Earnings Details
3/8/2011$0.03$0.04ViewN/AView Earnings Details
11/11/2010Q3 2010$0.01$0.05ViewN/AView Earnings Details
8/16/2010Q2 2010$0.03$0.01ViewN/AView Earnings Details
5/13/2010Q1 2010$0.02$0.02ViewN/AView Earnings Details
3/10/2010Q4 2009$0.01$0.01ViewN/AView Earnings Details
11/10/2009Q3 2009$0.01$0.10ViewN/AView Earnings Details
8/27/2009Q2 2009$0.02ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Cumberland Pharmaceuticals (NASDAQ:CPIX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Cumberland Pharmaceuticals (NASDAQ CPIX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 39.50%
Institutional Ownership Percentage: 34.58%
Insider Trading History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Institutional Ownership by Quarter for Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals (NASDAQ CPIX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/19/2018Michael BonnerCFOBuy300$6.72$2,016.0015,997View SEC Filing  
11/22/2017Michael BonnerCFOBuy250$7.81$1,952.5015,697View SEC Filing  
11/20/2017Kenneth KrogulskiDirectorBuy3,300$7.55$24,915.00154,300View SEC Filing  
8/23/2017Michael BonnerCFOBuy500$6.72$3,360.0015,447View SEC Filing  
5/31/2017Michael BonnerCFOBuy300$6.95$2,085.0014,947View SEC Filing  
4/7/2017Thomas R. LawrenceDirectorSell6,000$6.40$38,400.00View SEC Filing  
3/23/2017Michael BonnerCFOBuy900$6.42$5,778.0012,800View SEC Filing  
11/17/2016Michael BonnerCFOBuy900$5.50$4,950.0011,900View SEC Filing  
8/17/2016Thomas R LawrenceDirectorSell3,000$4.60$13,800.0045,381View SEC Filing  
5/26/2016Thomas R LawrenceDirectorSell3,000$4.55$13,650.0048,381View SEC Filing  
11/19/2015Thomas R LawrenceDirectorSell4,000$5.61$22,440.0050,381View SEC Filing  
3/19/2015Thomas R LawrenceDirectorSell6,000$6.95$41,700.00View SEC Filing  
11/20/2014Thomas R LawrenceDirectorSell10,000$5.12$51,200.00View SEC Filing  
8/21/2014Thomas R LawrenceDirectorSell15,000$5.08$76,200.00View SEC Filing  
3/19/2014Thomas LawrenceDirectorSell20,000$4.54$90,800.0080,381View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Cumberland Pharmaceuticals (NASDAQ CPIX) News Headlines

Source:
DateHeadline
Cumberland Pharmaceuticals Forecasted to Post Q1 2018 Earnings of ($0.02) Per Share (CPIX)Cumberland Pharmaceuticals Forecasted to Post Q1 2018 Earnings of ($0.02) Per Share (CPIX)
www.americanbankingnews.com - April 19 at 7:12 AM
Cumberland Pharmaceuticals (CPIX) Earns Buy Rating from Analysts at B. RileyCumberland Pharmaceuticals (CPIX) Earns Buy Rating from Analysts at B. Riley
www.americanbankingnews.com - April 17 at 9:19 AM
Cumberland Pharmaceuticals Expands into Oncology SupportCumberland Pharmaceuticals Expands into Oncology Support
finance.yahoo.com - April 9 at 9:55 AM
Why Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) Ownership Structure Is ImportantWhy Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) Ownership Structure Is Important
finance.yahoo.com - March 29 at 4:18 PM
Newly Published Data Demonstrates 85% Eradication of Ulcer Causing BacteriaNewly Published Data Demonstrates 85% Eradication of Ulcer Causing Bacteria
finance.yahoo.com - March 26 at 10:08 AM
Cumberland Pharmaceuticals (CPIX) & The Competition Critical ReviewCumberland Pharmaceuticals (CPIX) & The Competition Critical Review
www.americanbankingnews.com - March 24 at 9:46 AM
Edited Transcript of CPIX earnings conference call or presentation 6-Mar-18 9:30pm GMTEdited Transcript of CPIX earnings conference call or presentation 6-Mar-18 9:30pm GMT
finance.yahoo.com - March 18 at 9:35 AM
Cumberland Pharmaceuticals (CPIX) Announces  Earnings ResultsCumberland Pharmaceuticals (CPIX) Announces Earnings Results
www.americanbankingnews.com - March 6 at 7:17 PM
Cumberland Pharmaceuticals Reports 25% Revenue Growth For The Full Year 2017Cumberland Pharmaceuticals Reports 25% Revenue Growth For The Full Year 2017
finance.yahoo.com - March 6 at 4:39 PM
Cumberland Pharmaceuticals, Inc. (CPIX) Shares Bought by Stonepine Capital Management LLCCumberland Pharmaceuticals, Inc. (CPIX) Shares Bought by Stonepine Capital Management LLC
www.americanbankingnews.com - March 6 at 2:57 PM
Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2017 Financial ResultsCumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2017 Financial Results
finance.yahoo.com - February 27 at 4:53 PM
Cumberland Pharmaceuticals (CPIX) to Release Quarterly Earnings on MondayCumberland Pharmaceuticals (CPIX) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - February 26 at 3:38 AM
Why You Need To Look At This Factor Before Buying Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)Why You Need To Look At This Factor Before Buying Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)
finance.yahoo.com - February 23 at 9:35 AM
Is Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) A Financially Sound Company?Is Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) A Financially Sound Company?
finance.yahoo.com - February 15 at 4:26 PM
Hospira (HSP) versus Cumberland Pharmaceuticals (CPIX) Head to Head AnalysisHospira (HSP) versus Cumberland Pharmaceuticals (CPIX) Head to Head Analysis
www.americanbankingnews.com - January 27 at 5:20 PM
Financial Comparison: Hospira (HSP) & Cumberland Pharmaceuticals (CPIX)Financial Comparison: Hospira (HSP) & Cumberland Pharmaceuticals (CPIX)
www.americanbankingnews.com - January 23 at 8:22 AM
Head to Head Review: Hospira (HSP) & Cumberland Pharmaceuticals (CPIX)Head to Head Review: Hospira (HSP) & Cumberland Pharmaceuticals (CPIX)
www.americanbankingnews.com - January 4 at 3:28 PM
The fastest-growing Nashville health care company of 2017 might surprise youThe fastest-growing Nashville health care company of 2017 might surprise you
finance.yahoo.com - December 27 at 5:59 PM
Is Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) Excessively Paying Its CEO?Is Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) Excessively Paying Its CEO?
finance.yahoo.com - December 25 at 6:42 PM
Who Owns Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)?Who Owns Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)?
finance.yahoo.com - December 15 at 5:28 PM
Cumberland Pharmaceuticals (CPIX) Downgraded to Sell at ValuEngineCumberland Pharmaceuticals (CPIX) Downgraded to Sell at ValuEngine
www.americanbankingnews.com - December 4 at 10:26 PM
Insider Buying: Cumberland Pharmaceuticals, Inc. (CPIX) Director Acquires 3,300 Shares of StockInsider Buying: Cumberland Pharmaceuticals, Inc. (CPIX) Director Acquires 3,300 Shares of Stock
www.americanbankingnews.com - November 24 at 7:52 PM
Cumberland Pharmaceuticals Inc (CPIX): How Much Growth Is Left In Healthcare?Cumberland Pharmaceuticals Inc (CPIX): How Much Growth Is Left In Healthcare?
finance.yahoo.com - November 24 at 11:03 AM
ETFs with exposure to Cumberland Pharmaceuticals, Inc. : November 14, 2017ETFs with exposure to Cumberland Pharmaceuticals, Inc. : November 14, 2017
finance.yahoo.com - November 14 at 5:55 PM
Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017
finance.yahoo.com - November 13 at 9:36 PM
Edited Transcript of CPIX earnings conference call or presentation 7-Nov-17 9:30pm GMTEdited Transcript of CPIX earnings conference call or presentation 7-Nov-17 9:30pm GMT
finance.yahoo.com - November 8 at 10:07 PM
Cumberland Pharmaceuticals Inc. to Host Earnings CallCumberland Pharmaceuticals Inc. to Host Earnings Call
finance.yahoo.com - November 7 at 10:55 PM
Cumberland Pharmaceutical Reports 27% Revenue Growth In The Third QuarterCumberland Pharmaceutical Reports 27% Revenue Growth In The Third Quarter
finance.yahoo.com - November 7 at 10:55 PM
Cumberland reports 3Q lossCumberland reports 3Q loss
finance.yahoo.com - November 7 at 10:55 PM
Cumberland Pharmaceuticals Inc. (CPIX) Issues  Earnings ResultsCumberland Pharmaceuticals Inc. (CPIX) Issues Earnings Results
www.americanbankingnews.com - November 7 at 6:34 PM
Cumberland Pharmaceuticals Inc. (CPIX) Set to Announce Quarterly Earnings on TuesdayCumberland Pharmaceuticals Inc. (CPIX) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - November 1 at 10:48 AM
Cumberland Pharmaceuticals to Announce Third Quarter 2017 Financial ResultsCumberland Pharmaceuticals to Announce Third Quarter 2017 Financial Results
finance.yahoo.com - October 31 at 6:38 PM
Should You Be Holding Cumberland Pharmaceuticals Inc (CPIX) Right Now?Should You Be Holding Cumberland Pharmaceuticals Inc (CPIX) Right Now?
finance.yahoo.com - October 30 at 4:17 PM
Cumberland Pharmaceuticals Inc (CPIX): Time For A Financial Health CheckCumberland Pharmaceuticals Inc (CPIX): Time For A Financial Health Check
finance.yahoo.com - October 27 at 10:33 PM
ETFs with exposure to Cumberland Pharmaceuticals, Inc. : October 25, 2017ETFs with exposure to Cumberland Pharmaceuticals, Inc. : October 25, 2017
finance.yahoo.com - October 25 at 7:04 PM
Cumberland Pharmaceuticals Inc. (CPIX) Set to Announce Quarterly Earnings on MondayCumberland Pharmaceuticals Inc. (CPIX) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - October 23 at 10:56 AM
ETFs with exposure to Cumberland Pharmaceuticals, Inc. : October 9, 2017ETFs with exposure to Cumberland Pharmaceuticals, Inc. : October 9, 2017
finance.yahoo.com - October 9 at 6:02 PM
Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
finance.yahoo.com - October 6 at 5:41 PM
Cumberland Pharmaceuticals Launches Promotion of Totect® in The U.S. for Emergency Oncology InterventionCumberland Pharmaceuticals Launches Promotion of Totect® in The U.S. for Emergency Oncology Intervention
finance.yahoo.com - September 25 at 12:16 PM
What Are The Drivers Of Cumberland Pharmaceuticals Inc’s (CPIX) Risks?What Are The Drivers Of Cumberland Pharmaceuticals Inc’s (CPIX) Risks?
finance.yahoo.com - September 13 at 6:41 PM
Edited Transcript of CPIX earnings conference call or presentation 8-Aug-17 8:30pm GMTEdited Transcript of CPIX earnings conference call or presentation 8-Aug-17 8:30pm GMT
finance.yahoo.com - August 12 at 3:55 AM
Cumberland reports 2Q lossCumberland reports 2Q loss
finance.yahoo.com - August 8 at 10:15 PM
Cumberland Pharmaceuticals Inc. (CPIX) Releases  Earnings ResultsCumberland Pharmaceuticals Inc. (CPIX) Releases Earnings Results
www.americanbankingnews.com - August 8 at 9:30 PM
Cumberland Pharmaceutical Reports Double Digit Revenue Growth For The Fourth Consecutive QuarterCumberland Pharmaceutical Reports Double Digit Revenue Growth For The Fourth Consecutive Quarter
finance.yahoo.com - August 8 at 5:13 PM
Cumberland Pharmaceuticals Inc. (CPIX) Scheduled to Post Quarterly Earnings on TuesdayCumberland Pharmaceuticals Inc. (CPIX) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - August 3 at 10:40 AM
Cumberland Pharmaceuticals To Announce Second Quarter 2017 Financial ResultsCumberland Pharmaceuticals To Announce Second Quarter 2017 Financial Results
finance.yahoo.com - August 1 at 6:08 PM
Cumberland Pharmaceuticals Begin U.S. Shipments Of Dexrazoxane For Oncology Patient SupportCumberland Pharmaceuticals Begin U.S. Shipments Of Dexrazoxane For Oncology Patient Support
finance.yahoo.com - July 31 at 5:23 PM
Cumberland Pharmaceuticals Inc. (CPIX) Set to Announce Earnings on MondayCumberland Pharmaceuticals Inc. (CPIX) Set to Announce Earnings on Monday
www.americanbankingnews.com - July 24 at 8:49 AM
Financial Contrast: Cumberland Pharmaceuticals (NASDAQ:CPIX) and Merus Labs International (MSLI)Financial Contrast: Cumberland Pharmaceuticals (NASDAQ:CPIX) and Merus Labs International (MSLI)
www.americanbankingnews.com - July 17 at 10:27 AM
ETFs with exposure to Cumberland Pharmaceuticals, Inc. : July 12, 2017ETFs with exposure to Cumberland Pharmaceuticals, Inc. : July 12, 2017
finance.yahoo.com - July 12 at 6:10 PM

SEC Filings

Cumberland Pharmaceuticals (NASDAQ:CPIX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Cumberland Pharmaceuticals (NASDAQ:CPIX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Cumberland Pharmaceuticals (NASDAQ CPIX) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.